| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 05/20/2009 | CN100489094C Proteins with altered immunogenicity and methods of making and using the same |
| 05/19/2009 | US7534938 Synthetic nucleic acid molecule for imparting multiple traits |
| 05/19/2009 | US7534935 Phospholipid:diacylglycerol acyltransferases |
| 05/19/2009 | US7534930 cell comprising an endochitinase, a stilbene synthase and a superoxide dismutase; encoded from a nucleic acid construct which comprises an internal ribosome entry site sequence; confer resistance to sigatoka |
| 05/19/2009 | US7534902 Blocking group(s) is released by reaction with trigger (phosphatase); optionally contains urea-containing group for attaching proteins, peptides or nucleic acids; rhodamine; kits |
| 05/19/2009 | US7534879 2'-O-methyl-phosphorothioate oligoribonucleotide modification; peptide nucleic acids, locked nucleic acids, and/or morpholino phosphorodiamidate oligonucleotides; splicing |
| 05/19/2009 | US7534878 Composition and methods of RNAi therapeutics for treatment of cancer and other neovascularization diseases |
| 05/19/2009 | US7534877 Non-M, non-O HIV-1 strains, fragments and uses |
| 05/19/2009 | US7534876 Lactobacillus acidophilus nucleic acid sequences encoding cell surface protein homologues and uses therefore |
| 05/19/2009 | US7534875 Compositions for glioma classification |
| 05/19/2009 | US7534873 Method and materials for quaternary amine catalyzed bisulfite conversion of cytosine to uracil |
| 05/19/2009 | US7534872 9-fluorenylmethoxycarbonyl group (FMOC) for solid phase synthesis on optic glass filters; genetic engineering |
| 05/19/2009 | US7534869 Small and intermediate conductance, calcium-activated potassium channels and uses thereof |
| 05/19/2009 | US7534865 Bt toxin receptors from lepidopteran insects |
| 05/19/2009 | US7534864 Bt toxin receptors from lepidopteran insects |
| 05/19/2009 | US7534856 PRO19624 antibodies |
| 05/19/2009 | US7534775 Methods and compositions for modulating cardiac contractility |
| 05/19/2009 | US7534773 reduces the expression of testosterone-repressed prostate message-2 provides therapeutic benefits in the treatment of cancer for example prostate cancer and renal cell cancer; Combined use with taxanes synergistically enhances cytotoxic chemosensitivity of androgen-independent prostate cancer |
| 05/19/2009 | US7534621 Method of producing probe medium and method of immobilizing probe using probe medium |
| 05/19/2009 | US7534604 Fusion polypeptides capable of activating receptors |
| 05/19/2009 | US7534603 Fusion protein delivery system and uses thereof |
| 05/19/2009 | US7534594 Polypeptides having cellulolytic enhancing activity and polynucleotides encoding same |
| 05/19/2009 | US7534589 Polymer grafting by polysaccharide synthases |
| 05/19/2009 | US7534588 diagnosing HBV, HCV and HIV of a suspected patient; different primer sets and specific probes |
| 05/19/2009 | US7534587 Microsatellite markers for plants of the genus Triticeae and use thereof |
| 05/19/2009 | US7534569 using a polymerase extension reaction; elongation of an initial polynucleotide along a template oligonucleotide which has a 3' portion complementary to a 3' portion of the initial polynucleotide; template oligonucleotide can comprise a 3'-terminal blocker to prevent extension of the template |
| 05/19/2009 | US7534568 Polymerase, cleavage agent, upstream primer and downstream cleavage resistant probe; kits; incubation, hybridization, cleavage and fluorescent signal measurement |
| 05/19/2009 | US7534566 Nucleic acid labeling method and liquid composition |
| 05/19/2009 | US7534564 Methods and compositions for polypeptide engineering |
| 05/19/2009 | US7534561 Nucleic acid array in situ fabrication methods and arrays produced using the same |
| 05/19/2009 | US7534560 Simple catalytic DNA biosensors for ions based on color changes |
| 05/19/2009 | US7534449 Targeted and high density drug loaded polymeric materials |
| 05/19/2009 | US7534448 encapsulate therapeutic compounds such as drugs, cellular materials or components, and antigens, and can have targeting ligands directly bound to the microparticle surface; tissue engineering matrices, wound dressings, bone repair or regeneration materials |
| 05/19/2009 | US7534445 isolated nucleotide sequences and degenerate sequences encoding the high molecular weight HMW protein; vaccines; antibodies; vectors |
| 05/19/2009 | US7534432 Suppressing acitivity to treat musculodegenerative disease |
| 05/19/2009 | US7534417 Nucleotide sequences coding 103P2D6-related protein for diagnosing various tumors; anticarcinogenic agents; genetic vaccines |
| 05/19/2009 | CA2428532C Lysate clearance and nucleic acid isolation using silanized silica matrices |
| 05/19/2009 | CA2032203C Amplification capture assay |
| 05/14/2009 | WO2009062084A2 Cleavable modifications to reducible poly(amido ethylenimine)s to enhance nucleotide delivery |
| 05/14/2009 | WO2009061852A2 Modulation of factor 9 expression |
| 05/14/2009 | WO2009061851A2 Modulation of factor 7 expression |
| 05/14/2009 | WO2009061216A1 Compositions and methods for altering the production of pigment in plants |
| 05/14/2009 | WO2009061130A2 Cell permeable runx3 recombinant proteins, polynucleotides encoding the same, and anticancer compositions including the same |
| 05/14/2009 | WO2009060281A2 Immune stimulatory oligoribonucleotide analogs containing modified oligophosphate moieties |
| 05/14/2009 | WO2009060122A2 Use of oligonucleotides with modified bases as antiviral agents |
| 05/14/2009 | WO2009042971A3 Synthetic 5'utrs, expression vectors, and methods for increasing transgene expression |
| 05/14/2009 | WO2009042910A9 Ship inhibition to direct hematopoietic stem cells and induce extramedullary hematopoiesis |
| 05/14/2009 | WO2009039198A3 Generation of hyperstable mrnas |
| 05/14/2009 | WO2009029293A3 Nucleic acid compounds for inhibiting myc gene expression and uses thereof |
| 05/14/2009 | WO2009026546A3 Methods of modifying support surfaces for the immobilization of particles and the use of the immobilized particles for analyzing nucleic acids |
| 05/14/2009 | WO2007059120A3 Allelic form of the hmga2 gene predisposing women to the formation of leiomyomas |
| 05/14/2009 | WO2007056332A3 Molecular diagnosis of autoimmune diseases |
| 05/14/2009 | WO2007001399A3 Compositions, splice variants and methods relating to cancer specific genes and proteins |
| 05/14/2009 | WO2006048877A3 Treatment of b-cell malignancies with fgfr3 inhibitors |
| 05/14/2009 | WO2005113823A3 Hyaluronan receptor for endocytosis, variants thereof, and methods of making and using same |
| 05/14/2009 | WO2005105142A3 Recombinant reverse transcriptases |
| 05/14/2009 | WO2005079363A3 Aptamer therapeutics useful in the treatment of complement-related disorders |
| 05/14/2009 | WO2005003299A3 Polynucleotides encoding novel guanylate binding proteins (gbp's) |
| 05/14/2009 | WO2004097001A3 Novel bacillus 029cel cellulase |
| 05/14/2009 | WO2004061125A3 Compositions, methods and systems for inferring bovine traits |
| 05/14/2009 | US20090126046 Plants having improved growth characteristics and method for making the same |
| 05/14/2009 | US20090126044 Synthetic genes encoding cry1ac |
| 05/14/2009 | US20090126042 for improving fiber quality and/or yield of a fiber producing plant, as well as methods of using such polynucleotides for producing plants having increased biomass/vigor/yield |
| 05/14/2009 | US20090126040 Plant Vernalization Independence (VIP) Genes, Proteins, and Methods Of Use |
| 05/14/2009 | US20090126037 Tomtato plants having higher levels of resistance to botrytis |
| 05/14/2009 | US20090126034 Environmentally Stable Sensors and Methods of Using the Same |
| 05/14/2009 | US20090125245 Methods For Rapid Forensic Analysis Of Mitochondrial DNA |
| 05/14/2009 | US20090124795 Mitochondrial Dosimeter |
| 05/14/2009 | US20090124794 hTERT GENE EXPRESSION REGULATORY GENE |
| 05/14/2009 | US20090124793 Corticotropin releasing factor 2 receptor agonists |
| 05/14/2009 | US20090124792 Fluorescent polymethine cyanine dyes |
| 05/14/2009 | US20090124571 Method for the synthesis of oligonucleotide derivatives |
| 05/14/2009 | US20090124567 Influenza Therapeutic |
| 05/14/2009 | US20090124549 administering to a patient infected with mycobacterium tuberculosis, a therapeutically effective amount of an isolated polypeptide ( a polypeptide covalently linked to a carrier); protective immune response |
| 05/14/2009 | US20090124545 Novel nucleic acid encoding a novel protein of candida albicans and uses thereof |
| 05/14/2009 | US20090124544 Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants |
| 05/14/2009 | US20090124539 Methods of treating infection |
| 05/14/2009 | US20090124009 Antisense modulation of ptp1b expression |
| 05/14/2009 | US20090124004 Insect desiccation resistance genes and uses thereof |
| 05/14/2009 | US20090124003 Modulators of odorant receptors |
| 05/14/2009 | US20090124002 Alpha-1d calcium channel expressed in atrium |
| 05/14/2009 | US20090123999 Nucleotide sequences invovled in plant disease resistance |
| 05/14/2009 | US20090123985 Method for fabricating aerogels and their application in biocomposites |
| 05/14/2009 | US20090123980 Process for producing l-arginine, l-ornithine or l-citrulline |
| 05/14/2009 | US20090123969 Novel fluorescent protein and gene encoding the same |
| 05/14/2009 | US20090123967 Modified spider silk proteins |
| 05/14/2009 | US20090123966 Hybrid portable origin of replication plasmids |
| 05/14/2009 | US20090123954 Multicolor bioluminescent visualization probe set, or single-molecule-format multicolor bioluminescent visualization probe |
| 05/14/2009 | US20090123942 Electrophysiological assays using oocytes that express human enac and the use of phenamil to improve the effect of enac enhancers in assays using membrane potential reporting dyes |
| 05/14/2009 | US20090123940 Molecules involved in synaptogenesis and uses therefor |
| 05/14/2009 | US20090123938 Contacting a candidate antagonist with a MCP-1 receptor polypeptide having an amino acid sequence at least 95% homologous to an extracellular domain of a specific sequence, and comparing the binding of MCP-1 to the receptor polypeptide; decreased binding indicates an antagonist |
| 05/14/2009 | US20090123924 Method for Breast Cancer Diagnosis |
| 05/14/2009 | US20090123922 Bead Bound Combinatorial Oligonucleoside Phosphorothioate And Phosphorodithioate Aptamer Libraries |
| 05/14/2009 | US20090123921 Immunoglobulin libraries |
| 05/14/2009 | US20090123920 Jak2 mutations |
| 05/14/2009 | US20090123918 Human Protooncogene TRG and Protein Encoded Therein |
| 05/14/2009 | US20090123916 Nucleic Acid Fragments and Specific Detection Method By Molecular Identification of Different Bacteria Species of the Genus Acinetobacter |
| 05/14/2009 | US20090123912 Methods for quantitating small RNA molecules |
| 05/14/2009 | US20090123911 Isolated staphylococcus dnax subunit and use thereof |
| 05/14/2009 | US20090123532 Oligonucleic acid-bearing composite and pharmaceutical composition containing the composite |